Amador Bioscience Upgrades European Hub to Leverage European Resources for Global Markets
Andu Bio announces that its European center will relocate to the Diepenbeek Health Campus in the Flemish Region of Belgium,and plans to hire 120 medical and biostatistics personnel from Hasselt University in the Flanders region. Driven by growth and demand, Andu Bio’s European Center is expected to continue expanding in the coming years.
Dipenbeke Health Industrial Park, Flemish Region, Belgium
In November 2021, Andu Biosciences’ European Center was officially established at the Corda Campus in Limburg Province, Belgium. As part of this upgrade, the center will relocate to the third wing of Bio Ville within the Diepenbeek Limburg Health Park, with the expansion project scheduled for completion in summer 2023. The comprehensive upgrade of Andu’s European Center not only provides a superior working environment capable of accommodating more top-tier talent, but also further meets business needs and facilitates access to additional European resources to serve the global market.
Prime Location, Broad Market Prospects
As a global leader in pharmaceutical development, Belgium provides fertile ground for the advancement of new drug research and development. Nearly 12.5% of Europe’s biotechnology R&D investment is conducted in Belgium. Currently, more than 1,800 drugs are under development in the country, including over 400 for cancer treatment and more than 200 for immune disorders. As of 2020, although Belgium accounted for only 2.6% of Europe’s population, it hosted a substantial share of clinical trials: 19% focused on cancer research, 17% on immune system disorders, 15% on pediatric diseases, and 13% on neurological disorders.
Dr. Wang Bing, Chairman and CEO of Andu Biostated: “Europe is our next key market. The province of Limburg not only boasts a strong strategic location but also has a solid academic reputation and expertise in life sciences and high technology. Leveraging our experience in this field, we can facilitate the development of the pharmaceutical industry in Flanders and other parts of Europe.”
“The health industry park in Diepenbeek, home to Andu Bio’s European Center, is growing into a major innovation hub in Europe’s healthcare sector, built on the integration of education, research, and commerce.”Tom Vandeput, Deputy Governor of Limburg ProvinceIndicated.
Continue to Deepen Industry Talent Co-Development Cooperation
Belgium boasts a large pool of highly skilled talent that meets the needs of biopharmaceutical companies. Hasselt University, which enjoys a strong reputation in biostatistics, is also located in the Flanders region. Andu Bio’s European Center plans to triple its workforce within four years, and Hasselt University along with other higher education institutions will be well-positioned to meet this demand.
Recently, Andu Biosciences signed a cooperation agreement with Hasselt University. Leveraging the establishment of Andu’s Belgium laboratory as an opportunity, both parties will enable Andu Biosciences to utilize the advanced infrastructure and laboratories of Hasselt University’s Biomedical Research Institute (BIOMED) and collaborate on contract research organization (CRO) services for drug development, with plans to launch their first joint development project in the first half of 2023.
“Hasselt University seeks numerous development opportunities for young talent while providing companies with the highly skilled professionals they need. The arrival of Andu Bio serves as a prime example of this.”Bernard Vanheusden, President of Hasselt Universityindicated.
From left to right: Jos Lantmeeters, Governor of Limburg Province, Belgium; Ms. Chen Xiaomin, COO of Andu Bio; Nina Bos, Head of the European Center of Andu Bio; Dr. Liang Meina, CTO of Andu Bio; Bernard Vanheusden, Rector of Hasselt University
Dr. Mei-Na Liang, CTO of AnDu Bio“He stated, ‘There is explosive demand for high-end talent in the biopharmaceutical industry, yet few educational programs in the United States and Europe are capable of cultivating such professionals. The Biomedical Research Institute at Hasselt University boasts outstanding academic excellence in the health sector and life sciences industry. Its laboratories are well-equipped, and its researchers possess comprehensive expertise. I am highly confident in this collaboration.’”